A multigene predictor of outcome in glioblastoma.

Neuro Oncol 2010 Jan 20;12(1):49-57. Epub 2009 Oct 20.

Department of Neuro-Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas 77401, USA.

Only a subset of patients with newly diagnosed glioblastoma (GBM) exhibit a response to standard therapy. To date, a biomarker panel with predictive power to distinguish treatment sensitive from treatment refractory GBM tumors does not exist. An analysis was performed using GBM microarray data from 4 independent data sets. An examination of the genes consistently associated with patient outcome, revealed a consensus 38-gene survival set. Worse outcome was associated with increased expression of genes associated with mesenchymal differentiation and angiogenesis. Application to formalin fixed-paraffin embedded (FFPE) samples using real-time reverse-transcriptase polymerase chain reaction assays resulted in a 9-gene subset which appeared robust in these samples. This 9-gene set was then validated in an additional independent sample set. Multivariate analysis confirmed that the 9-gene set was an independent predictor of outcome after adjusting for clinical factors and methylation of the methyl-guanine methyltransferase promoter. The 9-gene profile was also positively associated with markers of glioma stem-like cells, including CD133 and nestin. In sum, a multigene predictor of outcome in glioblastoma was identified which appears applicable to routinely processed FFPE samples. The profile has potential clinical application both for optimization of therapy in GBM and for the identification of novel therapies targeting tumors refractory to standard therapy.

Download full-text PDF

Source
http://dx.doi.org/10.1093/neuonc/nop007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2940562PMC
January 2010
30 Reads

Publication Analysis

Top Keywords

predictor outcome
12
outcome glioblastoma
8
9-gene set
8
ffpe samples
8
standard therapy
8
multigene predictor
8
outcome
5
methylation methyl-guanine
4
methyl-guanine methyltransferase
4
associated increased
4
outcome associated
4
worse outcome
4
increased expression
4
factors methylation
4
mesenchymal differentiation
4
adjusting clinical
4
clinical factors
4
associated mesenchymal
4
genes associated
4
set worse
4

References

(Supplied by CrossRef)

Burton et al.
Cancer Research 2002

Freije et al.
Cancer Research 2004

Haas-Kogan et al.
Cell cycle (Georgetown, Tex.) 2005

Hegi et al.
New England Journal of Medicine 2005

Mellinghoff et al.
New England Journal of Medicine 2005

Nigro et al.
Cancer Research 2005

Stupp et al.
New England Journal of Medicine 2005

Ransohoff et al.
Nature reviews. Cancer 2004

Journal of Clinical Oncology 2005

Nutt et al.
Cancer Research 2003

Phillips et al.
Cancer cell 2006

Similar Publications